![BKM-120](https://img.chemicalbook.com/ProductImageEN/2019-8/Large/bcc750b8-b34a-41b9-926f-3d03e8c109a6.png)
BKM-120
Price | $3 |
Package | 3KG |
Min. Order: | 1KG |
Supply Ability: | 100kg |
Update Time: | 2019-08-07 |
Product Details
Product Name: BKM-120 | CAS No.: 1202777-78-3 |
Min. Order: 1KG | Purity: 99% |
Supply Ability: 100kg | Release date: 2019/08/07 |
Product model: windy |
▼
▲
BKM-120 Basic information
Description In vitro In vivo
▼
▲
Product Name:
BKM-120
Synonyms:
BKM-120;buparlisib/BKM120
CAS:
1202777-78-3
MF:
C18H21F3N6O2
MW:
410.3935496
EINECS:
Product Categories:
-
Mol File:
1202777-78-3.mol
![Article illustration](https://www.chemicalbook.com/CAS/20180906/GIF/1202777-78-3.gif)
▼
▲
BKM-120 Chemical Properties
▼
▲
CAS DataBase Reference
1202777-78-3
▼
▲
Safety Information
▼
▲
▼
▲
MSDS Information
▼
▲
BKM-120 Usage And Synthesis
▼
▲
Description
Buparlisib (BKM120, NVP-BKM120) is a selective PI3K inhibitor of p110α/β/δ/γ with IC50 of 52 nM/166 nM/116 nM/262 nM in cell-free assays, respectively. Reduced potency against VPS34, mTOR, DNAPK, with little activity to PI4Kβ. Phase 2.
In vitro
BKM120 is not sensitive to Class III and Class IV PI3K's or PI4K. NVP-BKM120 shows great antiproliferation activity to PI3K deregulated cell lines including A2780, U87MG, MCF7 and DU145 with GI50 of 0.1-0.7 nM. BKM120 induces multiple myeloma cells (ARP1, ARK, MM.1S, MM1.R and U266) apoptosis, which results in increased G1-phase cells and decreased S-phase cells. BKM120 induced CD138+ primary MM cell apoptosis and has significant lower cytotoxicity toward CD138? stromal cells. BKM120 exposure could cause upregulation of BimS and downregulation of XIAP. BKM120 demonstrates antiproliferative activity in human gastric cancer cell lines by decreasing mTOR downstream signaling. BKM120 could increase either p-ERK or p-STAT3 in KRAS mutant gastric cancer cells. Combination with STAT3 blockade, BKM120 shows a synergism in cells harboring mutated KRAS by inducing apoptosis, but not in KRAS wild-type cells. A recent study shows that BKM120 shows differential forms of cell death on the basis of p53 status of the cells with p53 wild-type cells undergoing apoptotic cell death and p53 mutant/deleted cells having a mitotic catastrophe cell death. BKM120 mediates mitotic catastrophe mainly through Aurora B kinase.
In vivo
BKM120 completely inhibits pAktser473 in A2780 xenograft tumors at doses of 30, 60, or 100 mg/kg, respectively. BKM120 also shows antitumor activity against U87MG glioma model at doses of 30 and 60 mg/kg. BKM120 treatment results in significantly reduced tumor volume and level of circulating human kappa chain at 5 μM/kg/day?1in ARP1 SCID mouse model, with prolonged survival.
Uses
A selective Class I PI3K inhibitor of p110α, p110β, p110δ and p110γ with IC50s of 50-300 nM.
Definition
ChEBI: An aminopyridine that is 4-(trifluoromethyl)pyridin-2-amine substituted at position 5 by a 2,6-di(morpholin-4-yl)pyrimidin-4-y group. A selective PI3K inhibitor with anti-tumour properties.
▼
▲
BKM-120 Preparation Products And Raw materials
Company Profile Introduction
Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals.
Mainly deals in the sales of:
Pharmaceutical intermediates
OLED intermediates:
Pharmaceutical intermediates;
OLED intermediates;
You may like
-
CAS:1208126-08-4
$3.00 / 3KG
-
CAS:122454-29-9
$3.00 / 3KG
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/1kg |
VIP1Y
|
Wuhan Fortuna Chemical Co.,Ltd
|
2024-08-26 | |
$20.00/1KG |
VIP5Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2024-08-09 | |
$3.60/1kg |
VIP1Y
|
Yujiang Chemical (Shandong) Co.,Ltd.
|
2024-05-30 |
- Since: 2014-12-17
- Address: No.967,15th Floor,Unit 7, Building 1, No.70 of DianChang Road, High-tech Development Zone, Zhengzho
INQUIRY
杨俊青
sales@coreychem.com
sales@coreychem.com